Search

Search Constraints

You searched for: Author/Creator Langohr, Klaus

Search Results

1. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. Issue 2 (February 2020)

5. Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Issue 2 (14th September 2013)

8. High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs. (1st June 2018)

10. Non-Linear Formation of EtG and FAEEs after Controlled Administration of Low to Moderate Doses of Ethanol. (7th June 2017)